Skip to main content
. Author manuscript; available in PMC: 2019 Jul 31.
Published in final edited form as: Circulation. 2018 Jul 31;138(5):513–526. doi: 10.1161/CIRCULATIONAHA.117.031635

Table 2.

Characterization of Heart Failure in BMP9−/− Mice After Two Weeks of TAC

WT Sham WT TAC BMP9−/− Sham BMP9−/− TAC Eng NAb BMP9−/− TAC
Mass
Total body weight (g) 24.5 ± 0.6 22.2 ± 1.4* 25.2 ± 1.5 21.5 ± 1.2 22.8 ± 3
LV mass (mg) 83 ± 7 149 ± 9* 88 ± 8 143 ± 12 157 ± 15
Lung mass (mg) 143 ± 6 349 ± 111* 137 ± 8 398 ± 58 379 ± 129
Tibia length (mm) 17.4 ± 0.1 17.5 ± 0.1 17.4 ± 0.2 17.5 ± 0.2 17.4 ± 0.2
LV/TL (mg/mm) 4.7 ± 0.4 8.5 ± 0.5* 5.2 ± 0.1 8.2 ± 0.8 8.9 ± 0.8
Lung/TL (mg/mm) 8.2 ± 0.4 20 ± 6.4* 7.9 ± 0.4 22.8 ± 3.2 21.7 ± 7.5
Hemodynamic data
Peak systolic pressure (mmHg) 95 ± 8 125 ± 12* 89 ± 2 96 ± 18 96 ± 10
End diastolic pressure (mmHg) 4 ± 2 22 ± 2* 6 ± 3 27 ± 4 28 ± 3
dP/dT max (mmHg/sec) 8449 ± 370 5463 ± 990* 8291 ± 645 2973 ± 517 3232 ± 178
dP/dT min (mmHg/sec) −8382 ± 577 −5253 ± 347* −7623 ± 637 −3156 ± 1020 −3523 ± 628
Ejection fraction (%) 62 ± 4 41 ± 5* 58 ± 7 28 ± 6 29 ± 5
Heart rate (bpm) 508 ± 62 546 ± 57 522 ± 48 562 ± 48 546 ± 68

Means±SD. p<0.05:

*

vs. WT Sham;

vs. BMP9−/− Sham;

vs. WT TAC